140 related articles for article (PubMed ID: 14501710)
1. Collecting duct carcinoma of the kidney: a clinicopathological study of 9 cases.
Peyromaure M; Thiounn N; Scotté F; Vieillefond A; Debré B; Oudard S
J Urol; 2003 Oct; 170(4 Pt 1):1138-40. PubMed ID: 14501710
[TBL] [Abstract][Full Text] [Related]
2. [Bellini renal cell carcinoma : diagnosis and treatment. A report of 7 cases].
Sallami S; Tanguour M; Ben Rhouma S; Cherif K; Kchir N; Horchani A
Tunis Med; 2011 Oct; 89(10):792-6. PubMed ID: 22076905
[TBL] [Abstract][Full Text] [Related]
3. Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literature.
Milowsky MI; Rosmarin A; Tickoo SK; Papanicolaou N; Nanus DM
Cancer; 2002 Jan; 94(1):111-6. PubMed ID: 11815966
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase inhibition with sunitinib.
Staehler M; Schöppler G; Haseke N; Stadler T; Karl A; Siebels M; Ihrler S; Stief CG
Clin Genitourin Cancer; 2009 Jan; 7(1):58-61. PubMed ID: 19213670
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase-inhibition with sunitinib.
Staehler M; Haseke N; Schöppler G; Stadler T; Karl A; Siebels M; Ihrler S; Stief CG
Eur J Med Res; 2008 Nov; 13(11):531-5. PubMed ID: 19073390
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study.
Sheng X; Cao D; Yuan J; Zhou F; Wei Q; Xie X; Cui C; Chi Z; Si L; Li S; Mao L; Lian B; Tang B; Yan X; Wang X; Kong Y; Dai J; Bai X; Zhou L; Guo J
Eur J Cancer; 2018 Sep; 100():1-7. PubMed ID: 29933095
[TBL] [Abstract][Full Text] [Related]
7. Triple combination of bevacizumab, gemcitabine and platinum salt in metastatic collecting duct carcinoma.
Pécuchet N; Bigot F; Gachet J; Massard C; Albiges L; Teghom C; Allory Y; Méjean A; Escudier B; Oudard S
Ann Oncol; 2013 Dec; 24(12):2963-7. PubMed ID: 24190963
[TBL] [Abstract][Full Text] [Related]
8. [Collecting duct renal cell carcinoma].
Husillos A; Herranz-Amo F; Subirá D; Lledó E; Molina-Escudero R; Hernández-Fernández C
Actas Urol Esp; 2011 Jun; 35(6):368-71. PubMed ID: 21450372
[TBL] [Abstract][Full Text] [Related]
9. [Effective palliative chemotherapy in a patient with collecting duct carcinoma of a unilateral kidney associated with anuria. Case report].
Kullmann T; Pintér T; Szepesvári Z; Kránitz N; Culine S
Orv Hetil; 2016 Mar; 157(11):436-9. PubMed ID: 26947093
[TBL] [Abstract][Full Text] [Related]
10. Response to paclitaxel, gemcitabine, and cisplatin in renal medullary carcinoma.
Bell MD
Pediatr Blood Cancer; 2006 Aug; 47(2):228. PubMed ID: 16514612
[No Abstract] [Full Text] [Related]
11. Major response and clinical benefit following third-line treatment for Bellini duct carcinoma.
Fakhrai N; Haitel A; Balassy C; Zielinski CC; Schmidinger M
Wien Klin Wochenschr; 2005 Jan; 117(1-2):63-5. PubMed ID: 15986594
[TBL] [Abstract][Full Text] [Related]
12. [Renal medullary carcinoma: remission with gemcitabine-cisplatin and review of therapeutic perspectives].
Diao B; Paule B; Esquivel S; Abbou CC; Salomon L; De La Taille A
Prog Urol; 2010 Jul; 20(7):538-41. PubMed ID: 20656278
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients?
Erten C; Demir L; Somali I; Alacacioglu A; Kucukzeybek Y; Akyol M; Can A; Dirican A; Bayoglu V; Tarhan MO
Asian Pac J Cancer Prev; 2013; 14(6):3711-7. PubMed ID: 23886170
[TBL] [Abstract][Full Text] [Related]
14. Nivolumab therapy for metastatic collecting duct carcinoma after nephrectomy: A case report.
Yasuoka S; Hamasaki T; Kuribayashi E; Nagasawa M; Kawaguchi T; Nagashima Y; Kondo Y
Medicine (Baltimore); 2018 Nov; 97(45):e13173. PubMed ID: 30407350
[TBL] [Abstract][Full Text] [Related]
15. Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study.
Oudard S; Banu E; Vieillefond A; Fournier L; Priou F; Medioni J; Banu A; Duclos B; Rolland F; Escudier B; Arakelyan N; Culine S;
J Urol; 2007 May; 177(5):1698-702. PubMed ID: 17437788
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24).
Thibault C; Fléchon A; Albiges L; Joly C; Barthelemy P; Gross-Goupil M; Chevreau C; Coquan E; Rolland F; Laguerre B; Gravis G; Pécuchet N; Elaidi RT; Timsit MO; Brihoum M; Auclin E; de Reyniès A; Allory Y; Oudard S
Eur J Cancer; 2023 Jun; 186():83-90. PubMed ID: 37054556
[TBL] [Abstract][Full Text] [Related]
17. Metastatic Collecting (Bellini) Duct Carcinoma Presented in a Young Patient: A Case Report and Review of the Literature.
Klang E; Lawson P; Yonat H; Michal Amitai M
Isr Med Assoc J; 2017 Dec; 19(12):777-778. PubMed ID: 29235742
[No Abstract] [Full Text] [Related]
18. Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy-resistant advanced renal cell carcinoma: final results of a single-institution Phase II study.
Porta C; Zimatore M; Imarisio I; Natalizi A; Sartore-Bianchi A; Danova M; Riccardi A
Cancer; 2004 May; 100(10):2132-8. PubMed ID: 15139055
[TBL] [Abstract][Full Text] [Related]
19. Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: Two cases.
Carden MA; Smith S; Meany H; Yin H; Alazraki A; Rapkin LB
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28052556
[TBL] [Abstract][Full Text] [Related]
20. Avelumab in metastatic collecting duct carcinoma of the kidney: a case report.
Pyrgidis N; Sokolakis I; Haltmair G; Heller V; Hatzichristodoulou G
J Med Case Rep; 2023 Jun; 17(1):262. PubMed ID: 37308983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
